PLEASANTON, Calif., Jan. 24,
2024 /PRNewswire/ -- 10x Genomics,
Inc. (Nasdaq: TXG), a leader in single cell and spatial
biology, today announced that it will report financial results for
the fourth quarter and full year ended December 31, 2023 after market close on
Thursday, February 15, 2024. The
company will host a public conference call and live webcast for
analysts and investors beginning at 1:30
p.m. Pacific Time / 4:30 p.m. Eastern
Time to discuss its results, business developments and
outlook. The news release with the financial results will be
accessible from the company's website prior to the conference
call.
Live audio of the webcast will be available on the "Investors"
section of the company website
at: www.10xgenomics.com. The webcast will be archived and
available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building
products to accelerate the mastery of biology and advance human
health. Our integrated solutions include instruments, consumables
and software for single cell and spatial biology, which help
academic and translational researchers and biopharmaceutical
companies understand biological systems at a resolution and scale
that matches the complexity of biology. Our products are behind
breakthroughs in oncology, immunology, neuroscience and more,
fueling powerful discoveries that are transforming the world's
understanding of health and disease. To learn more,
visit 10xgenomics.com or connect with us
on LinkedIn or X (Twitter).
Disclosure Information
10x Genomics uses filings with the Securities and Exchange
Commission, its website (www.10xgenomics.com), press releases,
public conference calls, public webcasts and its social media
accounts as means of disclosing material non-public information and
for complying with its disclosure obligations under Regulation
FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-15-2024-302043784.html
SOURCE 10x Genomics, Inc